{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:54:18Z","timestamp":1792079658847,"version":"4.4.0"},"reference-count":46,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Background and Objectives: Uterine leiomyomas are common benign tumors, whereas uterine sarcomas are rare but aggressive malignancies. Preoperative differentiation among leiomyoma, smooth muscle tumor of uncertain malignant potential (STUMP), and uterine sarcoma remains a major clinical challenge, with diagnosis often established only after histopathological evaluation. The identification of reliable circulating biomarkers could improve preoperative risk stratification and guide surgical decision-making. This study aimed to evaluate the usefulness of galectin-1 and mucin-1 in the diagnosis of uterine tumors. Materials and methods: This prospective, single-center case\u2013control study was conducted at the Third Department of Obstetrics &amp; Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Greece, between 2013 and 2024. Serum galectin-1 and mucin-1 levels were measured preoperatively using ELISA and electrochemiluminescence immunoassay (ECLIA), respectively. Group comparisons were performed using non-parametric tests. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Multivariable logistic regression was used to assess independent associations with sarcomas\/STUMP status. Results: The study population comprised 156 women (49 healthy controls, 90 patients with uterine myomas, 8 with STUMP and 9 patients with uterine sarcomas) treated during the study period. Galectin-1 differed significantly across the four histological groups (p &lt; 0.001), with higher concentrations in uterine sarcoma than in healthy controls (p &lt; 0.001) and leiomyoma (p = 0.002). MUC1 also differed overall (p = 0.031), with higher concentrations in uterine sarcoma than in leiomyoma (adjusted p = 0.031). In the primary leiomyoma versus sarcoma\/STUMP ROC analysis, galectin-1 showed modest discrimination (AUC 0.693, 95% CI 0.559\u20130.826), while MUC1 showed weaker discrimination (AUC 0.618, 95% CI 0.468\u20130.768). Conclusions: Serum galectin-1 may have potential as an adjunctive biomarker in the preoperative assessment of uterine tumors, but its modest discrimination and unstable cutoff-dependent performance may preclude its use as a standalone diagnostic test. MUC1 showed limited diagnostic utility in the primary clinical comparison. Given the clinical implications of misdiagnosis, particularly regarding surgical management, further validation in larger cohorts and multimarker approaches are warranted.<\/jats:p>","DOI":"10.3390\/cimb48090948","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:07:29Z","timestamp":1789574849000},"page":"948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Performance of Galectin-1 and Mucin-1 in Uterine Tumors: A Case\u2013Control Study"],"prefix":"10.3390","volume":"48","author":[{"given":"Paraskevi","family":"Karioti","sequence":"first","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Aikaterini","family":"Sidera","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-7871","authenticated-orcid":false,"given":"Ioannis","family":"Tsakiridis","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4844-2712","authenticated-orcid":false,"given":"Areti","family":"Kourti","sequence":"additional","affiliation":[{"name":"Laboratory of Biological Chemistry, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Georgios","family":"Karavas","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-5839","authenticated-orcid":false,"given":"Themistoklis","family":"Dagklis","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-0765","authenticated-orcid":false,"given":"Apostolos","family":"Mamopoulos","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Apostolos","family":"Athanasiadis","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2718-7480","authenticated-orcid":false,"given":"Kali","family":"Makedou","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Ioannis","family":"Kalogiannidis","sequence":"additional","affiliation":[{"name":"Third Department of Obstetrics and Gynecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence","volume":"188","author":"Dunson","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/1471-0528.14730","article-title":"Uterine fibroids: From observational epidemiology to clinical management","volume":"124","author":"Vercellini","year":"2017","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2023.06.016","article-title":"Uterine sarcomas: A critical review of the literature","volume":"287","author":"Giannini","year":"2023","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","article-title":"Uterine sarcomas: A review","volume":"116","author":"Prat","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.3390\/curroncol31090388","article-title":"Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Systematic Review of the Literature in the Last 20 Years","volume":"31","author":"Bucuri","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lewis, T.D., Malik, M., Britten, J., San Pablo, A.M., and Catherino, W.H. (2018). A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma. BioMed Res. Int., 2018.","DOI":"10.1155\/2018\/2414609"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","article-title":"Uterine leiomyosarcoma: A review of the literature and update on management options","volume":"151","author":"Roberts","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.21873\/anticanres.14064","article-title":"Recurrent Uterine Smooth-Muscle Tumors of Uncertain Malignant Potential (STUMP): State of The Art","volume":"40","author":"Rizzo","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/13625187.2022.2112169","article-title":"Investigation and management of abnormal uterine bleeding in reproductive-aged women: A descriptive review of national and international recommendations","volume":"27","author":"Tsakiridis","year":"2022","journal-title":"Eur. J. Contracept. Reprod. Health Care"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Liu, J., and Wang, Z. (2022). Advances in the Preoperative Identification of Uterine Sarcoma. Cancers, 14.","DOI":"10.3390\/cancers14143517"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ijgo.70538","article-title":"Diagnosis and classification of uterine fibroids","volume":"171","author":"Lakabi","year":"2025","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2214\/AJR.17.19234","article-title":"Uterine Leiomyosarcoma: Can MRI Differentiate Leiomyosarcoma from Benign Leiomyoma Before Treatment?","volume":"211","author":"DeMulder","year":"2018","journal-title":"Am. J. Roentgenol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"\u00d6zmaskan, F., G\u00fcnd\u00fcz, R., \u00c7al\u0131\u015f\u0131r, U., Kaydal, M., Sengi, A., and Duran, M. (2026). Histopathological Outcomes of Myoma Uteri Surgery Over a 10-Year Period: A Retrospective Evaluation of Sarcoma, STUMP, and Benign Variants. Int. J. Womens Health, 18.","DOI":"10.2147\/IJWH.S576026"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: From the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1136\/ijgc-2024-005823","article-title":"ESGO\/EURACAN\/GCIG guidelines for the management of patients with uterine sarcomas","volume":"34","author":"Casali","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0000000000001187","article-title":"Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated with Morcellation","volume":"127","author":"Tucker","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/cncr.28844","article-title":"Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma","volume":"120","author":"George","year":"2014","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.11.011","article-title":"Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: A systematic review and meta-analysis","volume":"137","author":"Bogani","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_20","unstructured":"U.S. Food and Drug Administration (FDA) (2026, July 01). UPDATE: Perform Only Contained Morcellation When Laparoscopic Power Morcellation Is Appropriate: FDA Safety Communication [Safety Communications] [Internet]. U.S. Food and Drug Administration (FDA), Available online: https:\/\/www.fda.gov\/medical-devices\/safety-communications\/update-perform-only-contained-morcellation-when-laparoscopic-power-morcellation-appropriate-fda#:~:text=The%20FDA%20recommends%20performing%20laparoscopic,only%20in%20appropriately%20selected%20patients."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.6004\/jnccn.2025.0038","article-title":"NCCN Guidelines\u00ae Insights: Uterine Neoplasms, Version 3.2025: Featured Updates to the NCCN Guidelines\u00ae","volume":"23","author":"Campos","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Hermenean, A., Oatis, D., Herman, H., Ciceu, A., D\u2019Amico, G., and Trotta, M.C. (2022). Galectin 1\u2014A Key Player between Tissue Repair and Fibrosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105548"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/j.1525-1438.2006.00741.x","article-title":"Increased expression of galectin-1 during the progression of cervical neoplasia","volume":"16","author":"Kohrenhagen","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: A multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gautam, S.K., Khan, P., Natarajan, G., Atri, P., Aithal, A., Ganti, A.K., Batra, S.K., Nasser, M.W., and Jain, M. (2023). Mucins as Potential Biomarkers for Early Detection of Cancer. Cancers, 15.","DOI":"10.3390\/cancers15061640"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.3233\/TUB-220023","article-title":"Oncology Biomarkers Section of the Catalan Association of Clinical Laboratory Science. Factors influencing blood tumor marker concentrations in the absence of neoplasia","volume":"46","author":"Auge","year":"2024","journal-title":"Tumour Biol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Smith, J., Zawaideh, J.P., Sahin, H., Freeman, S., Bolton, H., and Addley, H.C. (2021). Differentiating uterine sarcoma from leiomyoma: BET1T2ER Check!. Br. J. Radiol., 94.","DOI":"10.1259\/bjr.20201332"},{"key":"ref_29","first-page":"8136","article-title":"Uterine smooth muscle tumors of uncertain malignant potential (STUMP): Pathology, follow-up and recurrence","volume":"7","author":"Gizzo","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Tinelli, A., D\u2019Oria, O., Civino, E., Morciano, A., Hashmi, A.A., Baldini, G.M., Stefanovic, R., Malvasi, A., and Pecorella, G. (2023). Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Comprehensive Multidisciplinary Update. Medicina, 59.","DOI":"10.3390\/medicina59081371"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/his.13515","article-title":"Predictors of adverse outcome in uterine smooth muscle tumours of uncertain malignant potential (STUMP): A clinicopathological analysis of 22 cases with a proposal for the inclusion of additional histological parameters","volume":"73","author":"Gupta","year":"2018","journal-title":"Histopathology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bpobgyn.2011.07.002","article-title":"Clinical presentation and diagnosis of uterine sarcoma, including imaging","volume":"25","author":"Wu","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Reichert, V.M.C., Alwafai, Z., Zygmunt, M.T., Vollmer, M., and K\u00f6hler, G. (2023). Accidental Morcellation of Uterine Leiomyosarcoma Influences Relapse Free Survival but Does Not Negatively Influence Overall Survival. J. Clin. Med., 12.","DOI":"10.3390\/jcm12020591"},{"key":"ref_34","unstructured":"Food and Drug Administration (US) (2014). Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: Safety Communication."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.placenta.2007.06.006","article-title":"Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas","volume":"28","author":"Jeschke","year":"2007","journal-title":"Placenta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6602493","article-title":"Galectin-1 as a potential cancer target","volume":"92","author":"Rabinovich","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.18632\/oncotarget.2299","article-title":"Expression and functions of galectin-7 in ovarian cancer","volume":"5","author":"Labrie","year":"2014","journal-title":"Oncotarget"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Labrie, M., De Araujo, L.O.F., Communal, L., Mes-Masson, A.M., and St-Pierre, Y. (2017). Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-13802-5"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.2147\/IJWH.S515826","article-title":"Exploring the Potential Causal Relationship of Galectin Levels and Gynecologic Cancers: A Two-Sample Mendelian Randomization Study","volume":"17","author":"Dong","year":"2025","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13048-021-00874-1","article-title":"Galectin-1 as a predictive biomarker in ovarian cancer","volume":"14","author":"Masoodi","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"32984","DOI":"10.18632\/oncotarget.26034","article-title":"Increased plasma levels of galectin-1 in pancreatic cancer: Potential use as biomarker","volume":"9","author":"Barranco","year":"2018","journal-title":"Oncotarget"},{"key":"ref_42","first-page":"451","article-title":"Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium","volume":"31","author":"Weissenbacher","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Pandey, S.N., Babu, M.A., Ali, H., Malathi, H., Maharana, L., Goyal, K., Rana, M., and Imran, M. (2025). MUC1 as a diagnostic biomarker and siRNA-based therapeutic target in breast cancer: A clinical chemistry perspective. Clin. Chim. Acta, 576.","DOI":"10.1016\/j.cca.2025.120387"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3892\/mco.2022.2594","article-title":"Expression of MUC1 in different tumours and its clinical significance (Review)","volume":"17","author":"Lan","year":"2022","journal-title":"Mol. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Engelstaedter, V., Heublein, S., Schumacher, A.L., Lenhard, M., Engelstaedter, H., Andergassen, U., Guenthner-Biller, M., Kuhn, C., Rack, B., and Kupka, M. (2012). Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-600"},{"key":"ref_46","first-page":"2185","article-title":"Determination of MUC1 in Sera of Ovarian Cancer Patients and in Sera of Patients with Benign Changes of the Ovaries with CA15-3, CA27.29, and PankoMab","volume":"32","author":"Jeschke","year":"2012","journal-title":"Anticancer Res."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:40:11Z","timestamp":1789576811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":46,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cimb48090948"],"URL":"https:\/\/doi.org\/10.3390\/cimb48090948","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}